Evolent Health (EVH) to Acquire Valence Health in $145M Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Evolent Health to Acquire Valence Health, Extending Breadth and Depth of Value-Based Care Offering
July 13, 2016 6:00 AM EDTWASHINGTON, July 13, 2016 /PRNewswire/ --Â Evolent Health, Inc. (NYSE: EVH) Evolent Health, Inc. ("Evolent") and Valence Health, Inc. ("Valence Health") announced today that they have entered into a definitive agreement for Evolent to acquire the majority of Valence Health's business for approximately $145 million.
The combination of Evolent and Valence Health brings together two innovative companies that serve health care providers in the... More
